Involvement of JAK2 and MAPK on type II nitric oxide synthase expression in skin-derived dendritic cells
In this report, we demonstrate that a fetal mouse skin-derived dendritic cell line produces nitric oxide (NO) in response to the endotoxin [lipopolysaccharide (LPS)] and to cytokines [tumor necrosis factor-alpha (TNF-alpha) and granulocyte-macrophage colony-stimulating factor (GM-CSF)]. Expression of the inducible isoform of NO synthase (iNOS) was confirmed by immunofluorescence with an antibody against iNOS. The tyrosine kinase inhibitor genistein decreased LPS- and GM-CSF-induced nitrite (NO(-2)) production. The effect of LPS and cytokines on NO(-2) production was inhibited by the Janus kinase 2 (JAK2) inhibitor tyrphostin B42. The p38 mitogen-activated protein kinase (p38 MAPK) inhibitor SB-203580 also reduced the NO(-2) production evoked by LPS, TNF-alpha, or GM-CSF, but it was not as effective as tyrphostin B42. Inhibition of MAPK kinase with PD-098059 also slightly reduced the effect of TNF-alpha or GM-CSF on NO(-2) production. Immunocytochemistry studies revealed that the transcription factor nuclear factor-kappaB was translocated from the cytoplasm into the nuclei of fetal skin-derived dendritic cells (FSDC) stimulated with LPS, and this translocation was inhibited by tyrphostin B42. Our results show that JAK2 plays a major role in the induction of iNOS in FSDC.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
1999 |
---|---|
Erschienen: |
1999 |
Enthalten in: |
Zur Gesamtaufnahme - volume:277 |
---|---|
Enthalten in: |
The American journal of physiology - 277(1999), 6 vom: 17. Dez., Seite C1050-7 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Cruz, M T [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 20.01.2000 Date Revised 20.09.2018 published: Print Citation Status MEDLINE |
---|
doi: |
10.1152/ajpcell.1999.277.6.C1050 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM10530543X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM10530543X | ||
003 | DE-627 | ||
005 | 20231222134402.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231222s1999 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1152/ajpcell.1999.277.6.C1050 |2 doi | |
028 | 5 | 2 | |a pubmed24n0351.xml |
035 | |a (DE-627)NLM10530543X | ||
035 | |a (NLM)10600756 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Cruz, M T |e verfasserin |4 aut | |
245 | 1 | 0 | |a Involvement of JAK2 and MAPK on type II nitric oxide synthase expression in skin-derived dendritic cells |
264 | 1 | |c 1999 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 20.01.2000 | ||
500 | |a Date Revised 20.09.2018 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a In this report, we demonstrate that a fetal mouse skin-derived dendritic cell line produces nitric oxide (NO) in response to the endotoxin [lipopolysaccharide (LPS)] and to cytokines [tumor necrosis factor-alpha (TNF-alpha) and granulocyte-macrophage colony-stimulating factor (GM-CSF)]. Expression of the inducible isoform of NO synthase (iNOS) was confirmed by immunofluorescence with an antibody against iNOS. The tyrosine kinase inhibitor genistein decreased LPS- and GM-CSF-induced nitrite (NO(-2)) production. The effect of LPS and cytokines on NO(-2) production was inhibited by the Janus kinase 2 (JAK2) inhibitor tyrphostin B42. The p38 mitogen-activated protein kinase (p38 MAPK) inhibitor SB-203580 also reduced the NO(-2) production evoked by LPS, TNF-alpha, or GM-CSF, but it was not as effective as tyrphostin B42. Inhibition of MAPK kinase with PD-098059 also slightly reduced the effect of TNF-alpha or GM-CSF on NO(-2) production. Immunocytochemistry studies revealed that the transcription factor nuclear factor-kappaB was translocated from the cytoplasm into the nuclei of fetal skin-derived dendritic cells (FSDC) stimulated with LPS, and this translocation was inhibited by tyrphostin B42. Our results show that JAK2 plays a major role in the induction of iNOS in FSDC | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a Enzyme Inhibitors |2 NLM | |
650 | 7 | |a Flavonoids |2 NLM | |
650 | 7 | |a Imidazoles |2 NLM | |
650 | 7 | |a Interleukin-1 |2 NLM | |
650 | 7 | |a Lipopolysaccharides |2 NLM | |
650 | 7 | |a NF-kappa B |2 NLM | |
650 | 7 | |a Proto-Oncogene Proteins |2 NLM | |
650 | 7 | |a Pyridines |2 NLM | |
650 | 7 | |a Tumor Necrosis Factor-alpha |2 NLM | |
650 | 7 | |a Tyrphostins |2 NLM | |
650 | 7 | |a alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide |2 NLM | |
650 | 7 | |a Granulocyte-Macrophage Colony-Stimulating Factor |2 NLM | |
650 | 7 | |a 83869-56-1 |2 NLM | |
650 | 7 | |a Genistein |2 NLM | |
650 | 7 | |a DH2M523P0H |2 NLM | |
650 | 7 | |a Nitric Oxide Synthase |2 NLM | |
650 | 7 | |a EC 1.14.13.39 |2 NLM | |
650 | 7 | |a Nitric Oxide Synthase Type II |2 NLM | |
650 | 7 | |a EC 1.14.13.39 |2 NLM | |
650 | 7 | |a Nos2 protein, mouse |2 NLM | |
650 | 7 | |a EC 1.14.13.39 |2 NLM | |
650 | 7 | |a Protein-Tyrosine Kinases |2 NLM | |
650 | 7 | |a EC 2.7.10.1 |2 NLM | |
650 | 7 | |a Jak2 protein, mouse |2 NLM | |
650 | 7 | |a EC 2.7.10.2 |2 NLM | |
650 | 7 | |a Janus Kinase 2 |2 NLM | |
650 | 7 | |a EC 2.7.10.2 |2 NLM | |
650 | 7 | |a Mitogen-Activated Protein Kinases |2 NLM | |
650 | 7 | |a EC 2.7.11.24 |2 NLM | |
650 | 7 | |a p38 Mitogen-Activated Protein Kinases |2 NLM | |
650 | 7 | |a EC 2.7.11.24 |2 NLM | |
650 | 7 | |a SB 203580 |2 NLM | |
650 | 7 | |a OU13V1EYWQ |2 NLM | |
650 | 7 | |a 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one |2 NLM | |
650 | 7 | |a SJE1IO5E3I |2 NLM | |
700 | 1 | |a Duarte, C B |e verfasserin |4 aut | |
700 | 1 | |a Gonçalo, M |e verfasserin |4 aut | |
700 | 1 | |a Carvalho, A P |e verfasserin |4 aut | |
700 | 1 | |a Lopes, M C |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The American journal of physiology |d 1945 |g 277(1999), 6 vom: 17. Dez., Seite C1050-7 |w (DE-627)NLM000012386 |x 0002-9513 |7 nnns |
773 | 1 | 8 | |g volume:277 |g year:1999 |g number:6 |g day:17 |g month:12 |g pages:C1050-7 |
856 | 4 | 0 | |u http://dx.doi.org/10.1152/ajpcell.1999.277.6.C1050 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 277 |j 1999 |e 6 |b 17 |c 12 |h C1050-7 |